全文获取类型
收费全文 | 13001篇 |
免费 | 523篇 |
国内免费 | 353篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 125篇 |
妇产科学 | 24篇 |
基础医学 | 393篇 |
口腔科学 | 9篇 |
临床医学 | 1159篇 |
内科学 | 2777篇 |
皮肤病学 | 11篇 |
神经病学 | 163篇 |
特种医学 | 242篇 |
外国民族医学 | 1篇 |
外科学 | 5861篇 |
综合类 | 2198篇 |
预防医学 | 278篇 |
眼科学 | 23篇 |
药学 | 480篇 |
1篇 | |
中国医学 | 81篇 |
肿瘤学 | 43篇 |
出版年
2024年 | 7篇 |
2023年 | 155篇 |
2022年 | 222篇 |
2021年 | 498篇 |
2020年 | 411篇 |
2019年 | 424篇 |
2018年 | 464篇 |
2017年 | 295篇 |
2016年 | 249篇 |
2015年 | 322篇 |
2014年 | 828篇 |
2013年 | 748篇 |
2012年 | 559篇 |
2011年 | 730篇 |
2010年 | 605篇 |
2009年 | 787篇 |
2008年 | 754篇 |
2007年 | 785篇 |
2006年 | 689篇 |
2005年 | 634篇 |
2004年 | 534篇 |
2003年 | 449篇 |
2002年 | 332篇 |
2001年 | 340篇 |
2000年 | 264篇 |
1999年 | 253篇 |
1998年 | 213篇 |
1997年 | 224篇 |
1996年 | 153篇 |
1995年 | 138篇 |
1994年 | 94篇 |
1993年 | 92篇 |
1992年 | 97篇 |
1991年 | 78篇 |
1990年 | 54篇 |
1989年 | 53篇 |
1988年 | 40篇 |
1987年 | 43篇 |
1986年 | 42篇 |
1985年 | 37篇 |
1984年 | 34篇 |
1983年 | 16篇 |
1982年 | 37篇 |
1981年 | 16篇 |
1980年 | 23篇 |
1979年 | 15篇 |
1978年 | 17篇 |
1977年 | 9篇 |
1974年 | 5篇 |
1973年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
111.
非体外循环冠状动脉旁路移植术在高危冠心病中的应用 总被引:4,自引:1,他引:3
目的 探讨用非体外循环冠状动脉旁路移植术(OPCAB)的方法,以避免体外循环对冠心病高危因素患者产生的不良影响。方法 对100例冠心病患者行OPCAB,其中69例伴有冠心外科手术的高危因素。血管病变主要涉及左、右冠状动脉各分支。结果 手术死亡1例(1.4%),手术转换2例(2.9%),移植血管失功1例(1.4%),术后非致命性心肌梗死4例(5.8%),肾功能衰竭1例(1.4%),胸骨感染1例(1.4%),24小时内拔除气管内插管68例(98.6%),接受输血17例(25.O%)。术后随访56例,随访时间1—13个月,死亡2例,心绞痛复发4例,充血性心力衰竭2例。术后无脑血管意外、再次手术止血、室性心律失常、下胶切口感染和呼吸衰竭等并发症发生。随访病例中14例做冠状动脉血管造影术,仅1例移植血管狭窄大于50%。所有乳内动脉血管桥均通畅。结论 对某些具有冠心外科手术高危因素的患者,采用OPCAB可降低并发症发生率和手术死亡率。然而,这种技术较适用于冠状动脉解剖条件较好的病例。远期结果需要长期随访进一步加以证实。 相似文献
112.
目的 总结冠状动脉旁路移植术治疗冠心病的体会。 方法 回顾性分析 3 0 6例冠状动脉旁路移植术。男 2 49例 ,女 5 7例。应用体外循环 2 3 4例 ,非体外循环 72例。搭桥数 1~ 6支 人 ,平均 (3 .45± 1.2 5 )支 人。对手术方法、主要并发症和术后处理进行分析总结。结果 二次开胸 5例 (1.6% ) ,低心排综合征 10例 (3 .3 % ) ,应用IABP4例 (1.3 % ) ,肝功能不全 6例 (2 .0 % )。肾功能不全 7例 (2 .3 % ) ,反复发作房颤 2 3例 (7.5 % ) ,肺功能不全 6例(2 .0 % ) ,脑合并症 3例 (1.0 % ) ,胸腔积液 41例 (13 .4% )。死亡 7例 (2 .3 % ) ,其余病人康复出院。结论 合理的选择病人 ,成熟的手术技术 ,良好的心肌保护及术后处理的加强是提高冠状动脉旁路移植术疗效的重要措施。 相似文献
113.
目的探讨羟乙基淀粉130/0.4预充液对先天性心脏病患儿围体外循环期血管内皮细胞(VEC)及血管通透性的影响。方法择期体外循环(CPB)下行心内直视手术的先天性心脏病患儿40例,ASAⅡ或Ⅲ级,男19例,女21例,年龄5~18岁,随机分为2组(n=20):血浆组(对照组)和羟乙基淀粉130/0.4组(试验组)。对照组预充乳酸林格氏液和血浆,试验组预充乳酸林格氏液和羟乙基淀粉130/0.4。胶体预充液用量18-33 m1·kg-1,晶体:胶体=0.60-0.70。分别于转流前即刻(T1)、转流30min(T2)、转流结束即刻(T3)、转流结束6 h(T4)、术后第1天清晨(T5)检测血浆循环内皮细胞(CEC)数量、内毒素、可溶性细胞间粘附分子-1(sICAM-1)、肿瘤坏死因子-α(TNF-α)及尿微量白蛋白(U-Mal)浓度。结果.T1时两组CEC、内毒素、sICAM-1、TNF-α、U-Mal差异无统计学意义(P>0.05)。CEC:两组T2、T3及T4时较T1增高,T4时试验组低于对照组(P<0.05)。内毒素:两组T2、T3、T4时较T1升高,T3、T4、T5时试验组低于对照组(P<0.05)。sICAM-1:对照组T4、T5时较T1升高,T4时试验组低于对照组(P<0.05)。TNF-α:对照组T3时较T1升高,试验组低于对照组(P<0.05)。U-Mal:两组T4时较T1升高,试验组低于对照组(P<0.05)。结论羟乙基淀粉130/0.4预充液对先天性心脏病患儿围体外循环期VEC及其功能具有保护作用。 相似文献
114.
The effect of calcium dobesilate on venous function following saphenectomy in coronary artery bypass grafting 总被引:1,自引:0,他引:1
Kerim Cagli Kanat Ozisik Mustafa Emir Okan Yurdakok Sami Gurkahraman Vedat Bakuy Muharrem Tola Mustafa Pac Adnan Cobanoglu 《Cardiovascular Revascularization Medicine》2006,7(4):212-216
BACKGROUND: The aim of this study was to determine whether prophylactic use of calcium dobesilate (CD) can improve venous function after saphenous vein harvest in coronary artery bypass graft (CABG). MATERIALS AND METHODS: A total of 100 patients who underwent elective CABG were divided into four equal groups. In Group A, the greater saphenous vein (GSV) was harvested below the knee and, in Group B, through the knee till the groin. These patients remained untreated. Group C received CD in a dosage of 1500 mg po daily after the GSV was harvested below the knee. Group D received same dosage of CD after the GSV was harvested through the knee till the groin. Venous function of ipsilateral leg was evaluated clinically and by Doppler ultrasonography in the postoperative first week and second month. RESULTS: Clinical findings of venous insufficiency were observed with a similar rate between groups at both early and late periods. In Groups A and B, after 2 months, flow velocities decreased and reflux periods increased significantly. In groups C and D, treatment with CD for 2 months after saphenectomy resulted in a significant increase in flow velocities and a significant decrease in reflux periods. Patients in Groups B and D have significantly more impaired venous functions. CONCLUSION: Saphenectomy results in ipsilateral leg venous dysfunction, which seems to be unrelated to leg swelling and to be more prominent in patients with high-level saphenectomy. In addition, to be careful about the restriction of the saphenectomy procedure into the most appropriate level, prophylactic use of CD can prevent this deterioration when it was added to varice socks. 相似文献
115.
116.
P. Peigh A. Fiore K. Naunheim G. Kaiser D.G. Pennington L. McBride V. Willman H. Barner 《European journal of cardio-thoracic surgery》1994,8(12):635-639
The purpose of this study was to determine if the addition of potassium to reinfusion cold blood cardioplegia (CBC) offers an advantage over cold blood alone. Forty patients matched for age, left ventricular function, extent of coronary disease and number of vessels bypassed were prospectively randomized. Each patient received an initial dose of CB C (10 cc/kg) with potassium. Group I patients (n=23) received subsequent infusions of CBC (5 cc/kg) containing potassium while Group II patients (n=17) received cold blood only. The cross-clamp time, mean infusate volume and temperature were not significantly different in the two groups. Following reperfusion, the cardiac index and the CPK isoenzyme release at 0.5, 1, 8, and 12 h after cross-clamp release were not significantly different between the groups. The postoperative appearance of new Q-waves, inotropic agent requirement, and reversal of the lactate dehydrogenase (LDH) isoenzyme ratio were also not significantly different in the two groups. The study demonstrated that following initial arrest with potassium, cold blood is equally as effective as potassium blood cardioplegia in protecting the ischemic myocardium. 相似文献
117.
U.M. Hodges BSc Hons MBBS FRCA S. Berg BSc MBBS FRCA S.K. Naik FRCS S. Bower MBChB PhD A. Lloyd-Thomas MBBS FRCA M. Elliot MD FRCS 《Journal of cardiothoracic and vascular anesthesia》1994,8(6)
Modified ultrafiltration after cardiopulmonary bypass in children has been shown to be associated with an increase in arterial blood pressure. As part of a series of studies to investigate the possible causes of this blood pressure elevation, the hypothesis that if filtration was removing a significant amount of fentanyl, then the increase in blood pressure might be due to pain was proposed. Ten children, aged between 0.5 and 9.3 years (median 3.8 years), weighing 5.9 to 25..5 kg (median 15.7 kg), underwent corrective cardiac surgery (incorporating modified ultrafiltration). A standard anesthetic protocol was followed, with up to 78 μg/kg of fentanyl given prebypass for analgesia. After completion of cardiopulmonary bypass, modified ultrafiltration was commenced at 100 mL/min until a hematocrit of 35% was reached. Samples were taken of arterial blood (prefiltration, 3, 10, and 20 minutes postfiltration), the venous reservoir blood (prefiltration) and the filtrate (5 and 10 minutes into filtration). Hemodynamic data were recorded both prefiltration and postfiltration. The hemodynamic data showed the expected rise in both systemic arterial pressure and cardiac index after ultrafiltration. The plasma fentanyl concentrations did not significantly change after ultrafiltration: 1.59 to 12.39 ng/mL (median 6.27 ng/mL) prefiltration and 2.05 to 15.59 ng/mL (6.29 ng/mL) at 3 minutes, 2.22 to 12.64 ng/mL (6.87 ng/mL) at 10 minutes, and 1.83 to 11.52 ng/mL (5.85 ng/mL) at 20 minutes postfiltration. The concentration of fentanyl in the venous reservoir, 2.06 to 11.64 ng/mL (7.04 ng/mL), was not significantly different from the plasma levels. The level of fentanyl in the filtrate was significantly less than the plasma levels, 0.243 to 1.87 ng/mL (0.894 ng/mL) at 5 minutes and 0.385 to 1.688 ng / mL (0.952 ng / mL) at 10 minutes into filtration; (P < 0.02 by the Wilcoxon signed-rank method). The data show that the plasma fentanyl concentration was not significantly reduced by modified ultrafiltration. The fentanyl levels found prefiltration were maintained postfiltration, and the observed changes in systemic arterial pressure were not due to an acute fall in the plasma concentration of analgesic drug. 相似文献
118.
119.
冠脉旁路移植术中桡动脉的获取和应用 总被引:1,自引:0,他引:1
目的总结冠状动脉旁路移植术中桡动脉的获取方法和早期临床效果。方法22例冠状动脉旁路移植术患者,行量化Allen试验决定是否切取桡动脉。桡动脉伴随静脉一起切取,术中不直接接触桡动脉,严格避免夹镊桡动脉本身;离断后腔内注入肝素罂粟碱液,并将桡动脉置于该液中备用。共获取桡动脉22根,远端吻合至冠状动脉后降支、钝缘支及前降支,近端均吻合至主动脉。术后常规应用钙通道阻滞剂12个月。结果术后患者心绞痛消失,心功能显著改善,无围术期心肌梗死。无术中桡动脉痉挛现象,围术期无出血、栓塞合并症,无手臂缺血发生。结论桡动脉移植物可常规应用于冠状动脉旁路移植术;严格的“免触”技术和术后应用钙通道阻滞剂是保证桡动脉良好功能的关键。 相似文献
120.
目的比较使用桡动脉和乳内动脉全动脉化冠状动脉旁路移植术(CABG)与使用一根乳内动脉和静脉做常规CABG的近期手术结果。方法从1999年1月到2005年1月,阜外心血管病医院共有123例患者(男114例、女9例,年龄52.2±10.1岁)采用全动脉化CABG(全动脉化组),血管移植材料为乳内动脉和桡动脉,目标血管桥在2根以上;同期行常规CABG115例(男102例、女13例,年龄60.3±9.1岁),血管的移植材料为一根乳内动脉和若干静脉桥(常规手术组)。比较两组患者术前、术中和术后的临床结果。结果术前资料比较,全动脉化组的患者年龄更小,常规手术组3支病变患者较多(54.5%vs.86.1%,P=0.001),全动脉化组有更多患者选择非体外循环CABG(26.0%vs.57.4%,P=0.001);在体外循环CABG中,全动脉化组需要更长的手术时间;平均移植血管根数全动脉化组少于常规手术组(2.6±0.7根vs.3.4±0.9根,P=0.001);住院死亡率全动脉化组为0.8%,常规手术组为0.9%,两组比较差异无统计学意义(P=1.000);术后近期并发症发生情况两组结果相似。结论对选择适合的患者采用全动脉化CABG能够提供较为安全的近期手术结果。 相似文献